Biodesix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biodesix and other ETFs, options, and stocks.About BDSX
Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer.
CEOScott Hutton
CEOScott Hutton
Employees273
Employees273
HeadquartersLouisville, Colorado
HeadquartersLouisville, Colorado
Founded2005
Founded2005
Employees273
Employees273
BDSX Key Statistics
Market cap66.99M
Market cap66.99M
Price-Earnings ratio-1.59
Price-Earnings ratio-1.59
Dividend yield—
Dividend yield—
Average volume40.44K
Average volume40.44K
High today$8.62
High today$8.62
Low today$8.08
Low today$8.08
Open price$8.08
Open price$8.08
Volume59.72K
Volume59.72K
52 Week high$32.20
52 Week high$32.20
52 Week low$3.44
52 Week low$3.44
Stock Snapshot
As of today, Biodesix(BDSX) shares are valued at $8.51. The company's market cap stands at 66.99M, with a P/E ratio of -1.59.
On 2025-12-05, Biodesix(BDSX) stock moved within a range of $8.08 to $8.62. With shares now at $8.51, the stock is trading +5.3% above its intraday low and -1.3% below the session's peak.
Trading volume for Biodesix(BDSX) stock has reached 59.72K, versus its average volume of 40.44K.
The stock's 52-week range extends from a low of $3.44 to a high of $32.20.
The stock's 52-week range extends from a low of $3.44 to a high of $32.20.
People also own
Based on the portfolios of people who own BDSX. This list is generated using Robinhood data, and it’s not a recommendation.